share_log
Moomoo 24/7 ·  Mar 28 12:02
Aldeyra Therapeutics Shares Are Trading Higher. The Company Announced the Clinical Development Plan Intended to Enable Resubmission of a New Drug Application for Reproxalap in Dry Eye Disease
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment